[Screening for colorectal cancer].
Colorectal cancer is the second leading cause of death in Northern countries and need a national screening program to reduce mortality and improve quality of life. Screening has to be cost-effective and acceptable for patients. Many screening tools, invasive or not, are existing and often debated: FOBT, sigmoidoscopy and complete colonoscopy. New tools are in development and have to be evaluated in current practice: virtual colonoscopy, new endoscopic technologies, DNA on faeces or proteomics with markers in serum.
Piront
P
P
Service de gastroentérologie, CHU Sart Tilman, CBIG-GIGA, ULg. Liège, Belgique.
Louis
E
E
Belaiche
J
J
Polus
M
M
D001530:Belgium / Q000453:epidemiology; D023881:Colonography, Computed Tomographic / Q000379:methods; D003113:Colonoscopy; D015179:Colorectal Neoplasms / Q000175:diagnosis* / Q000453:epidemiology / Q000235:genetics; D004247:DNA / Q000737:chemistry / Q000302:isolation & purification; D005243:Feces / Q000737:chemistry; D014943:Global Health; D006801:Humans; D015994:Incidence; D008403:Mass Screening; D009780:Occult Blood; D012812:Sigmoidoscopy; D016019:Survival Analysis
D004247:DNA